CorFlow Therapeutics is a medtech startup focused on developing innovative technologies for the diagnosis and treatment of microvascular obstructions in patients experiencing heart attacks. The company has created a controlled flow infusion system that utilizes a proprietary concept to measure microvascular resistance, allowing interventional cardiologists to assess the severity of microvascular obstruction. By comparing these measurements with post-procedure contrast-enhanced magnetic resonance imaging, CorFlow's technology aims to improve the diagnosis and treatment of microvascular obstruction, potentially reducing both short- and long-term complications for severe heart attack patients. Through its advancements, CorFlow is committed to addressing significant unmet medical needs in cardiology.
Boulder Care
Venture Round in 2024
Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.
Ciconia Medical
Pre Seed Round in 2024
Ciconia Medical is a developer of innovative medical devices focused on enhancing maternal health during childbirth. The company has created an AI-based vaginal examination tool designed to reduce unnecessary invasiveness, pain, and risks associated with labor. This technology enables clinicians to make informed decisions based on accurate and consistent measurements, ensuring a safer and gentler experience for both mothers and their newborns. Ciconia Medical's commitment to improving childbirth outcomes positions it as a significant player in the field of maternal health.
Avive
Venture Round in 2024
Avive Solutions, Inc., established in 2017, is a medical technology company based in San Francisco, California. It specializes in the development of Automated External Defibrillators (AEDs) and accompanying software solutions. Avive's primary focus is to remove barriers and simplify the response to Sudden Cardiac Arrest (SCA), empowering anyone to effectively intervene in such emergencies. Their next-generation AED is designed to be easily accessible, user-friendly, and well-maintained, with a connected platform that facilitates data transfer to emergency services and medical professionals, enhancing post-rescue care.
AMOpportunities
Series A in 2023
Founded in 2013 and headquartered in Chicago, Illinois, AMOpportunities connects international medical students with clinical training opportunities in the U.S. Through its platform, it offers access to over 200 clinical sites across 70+ specialties, providing visa assistance and housing support.
Cardiosense
Series A in 2022
Cardiosense is a company that focuses on developing a physiological waveform AI platform aimed at creating predictive biomarkers for disease detection and treatment. By mining raw biosignals, Cardiosense provides enhanced visibility into cardiac functions and employs advanced signal processing techniques to identify pre-symptomatic markers of cardiac disease. The company specializes in utilizing non-invasive sensors and proprietary algorithms, which allow healthcare professionals to monitor and analyze cardiac health signals effectively. This innovative approach enables the early detection of diseases, thereby facilitating improved patient care and health tracking.
Boulder Care
Series B in 2022
Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.
Avive Solutions, Inc., established in 2017, is a medical technology company based in San Francisco, California. It specializes in the development of Automated External Defibrillators (AEDs) and accompanying software solutions. Avive's primary focus is to remove barriers and simplify the response to Sudden Cardiac Arrest (SCA), empowering anyone to effectively intervene in such emergencies. Their next-generation AED is designed to be easily accessible, user-friendly, and well-maintained, with a connected platform that facilitates data transfer to emergency services and medical professionals, enhancing post-rescue care.
RelianceHMO
Series B in 2022
Kangpe Nigeria Limited operates a telemedicine platform that connects patients with doctors for online health consultations. Founded in 2015 and based in Lagos, Nigeria, the company offers subscription-based services allowing patients to ask health-related questions and receive medical advice. Doctors on the platform provide guidance on symptoms, disease diagnosis, and treatment based on detailed descriptions of patients' health conditions. Kangpe aims to make health services more accessible and affordable by leveraging technology, ensuring that patients can articulate their medical history and current issues to facilitate accurate diagnoses and effective treatment recommendations.
Reliance Health
Series B in 2022
Reliance Health is a healthcare technology company focused on enhancing the affordability and accessibility of healthcare in emerging markets. It employs an integrated approach that combines affordable health insurance with telemedicine services, alongside a network of both partner and proprietary healthcare facilities. This strategy aims to provide comprehensive care solutions for organizations, families, and individuals, helping them effectively manage their health concerns. By leveraging technology and innovative service delivery models, Reliance Health seeks to improve health outcomes and reduce the financial burdens associated with healthcare.
Tele911
Venture Round in 2021
Tele911 is a technology company that partners with EMS providers to care for stable patients through a Tele911 Virtual Visit. It has developed a patient-centered emergency care platform that integrates telemedicine and patient navigation into EMS workflows, offering alternatives to medically unnecessary ambulance transports to hospital emergency departments. The platform aims to improve patient access to timely care while reducing costs and conserving EMS resources.
Aloe Care Health
Seed Round in 2021
Aloe Care Health develops a voice-activated, in-home digital care assistant for older adults. Its flagship product, Aloe Care, offers features such as voice-activated communication, fall detection, access to an emergency call center, and smart sensors to monitor motion, air quality, and temperature.
MobileODT
Series C in 2020
MobileODT Ltd is a company specializing in the development of optical diagnostic devices and software services aimed at early cancer detection. Based in Tel Aviv, Israel, with an additional location in New York, MobileODT offers a range of products, including the FDA-cleared EVA COLPO, a portable and Internet-connected colposcope, and EVA SANE, a secure platform for managing patient information. The company's Enhanced Visual Assessment (EVA) System enhances the capabilities of healthcare providers, enabling them to conduct examinations comparable to those performed by expert practitioners. MobileODT's tools are utilized in various challenging environments and have been employed in over 40,000 procedures across 29 countries. The company's offerings also include applications for documenting cases of violence and abuse, as well as cloud-based solutions for managing patient data. With a growing presence in the United States, MobileODT is establishing itself as a leader in visual diagnostic technology, expanding into new markets and developing additional applications for diverse medical fields.
RapidSOS, Inc. is an emergency response data platform that connects life-saving information from over 350 million devices directly to 9-1-1 and first responders during emergencies. Founded in 2012 and based in New York, the company offers a range of solutions including Clearinghouse, which enables users to send emergency requests from RapidSOS-enabled devices, and an Emergency API suite that delivers user data to emergency services. Additionally, the RapidSOS Portal provides public safety agencies with secure access to essential Next Generation 911 (NG911) data. The platform supports more than 4,800 Emergency Communications Centers and plays a vital role in protecting over 90% of the U.S. population, responding to approximately 250 million emergencies annually. By collaborating with certified partners, RapidSOS enhances response capabilities by transmitting critical data such as precise location and real-time health information, ultimately aiming to improve emergency response efficiency and save lives.